Literature DB >> 7931189

Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: changes during the natural history and with interferon-alpha therapy in patients with hepatitis B virus infection.

A P Catterall1, I M Murray-Lyon, A J Zuckerman, T J Harrison.   

Abstract

Hepatitis B virus (HBV) DNA was evaluated in peripheral blood mononuclear cells (PBMC) from 50 individuals utilising Southern hybridisation analysis. HBV DNA sequences were detected in PBMC from 16/29 (55 percent) of chronic hepatitis B virus (HBV) carriers with serum HBeAg and HBV DNA, compared with 1/8 (13%) of carriers with anti-HBe and HBV DNA negative (P = NS). Two of 7 patients with previous HBV infection and chronic liver disease had detectable HBV DNA in PBMC. Of the 19 patients with HBV DNA in PBMC, 18 had high molecular weight species. In addition, five of these had free, monomeric HBV DNA and six patients had low molecular weight bands. For nine of the above patients, total peripheral blood leucocytes were separated into PBMC and polymorphonuclear cells. Four had HBV DNA in PBMC only, two only in polymorphonuclear cells and three in both types of cell. Eleven patients with chronic HBV infection were studied at monthly intervals for 6 months. Six were untreated and five received IFN-alpha. Three patients who responded to IFN-alpha had HBV DNA present in PBMC before therapy, and two became negative. Two of 3 untreated patients had intermittent HBV DNA in PBMC and the other remained persistently negative. Of the patients positive on more than one occasion, the pattern of HBV DNA was similar. Peripheral blood leucocytes often contain multimers of free HBV DNA, more commonly in patients with serum HBeAg and HBV DNA and may occur even in the absence of serum HBsAg. These findings have implications for recurrence of disease after hepatic transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931189     DOI: 10.1002/jmv.1890430314

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells.

Authors:  Kai-Fu Tang; Min Chen; Jing Xie; Guan-Bin Song; Yi-Song Shi; Qi Liu; Zhe-Chuan Mei; Alexander Steinle; Hong Ren
Journal:  Med Microbiol Immunol       Date:  2008-08-07       Impact factor: 3.402

3.  Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.

Authors:  Jie Ruan; Shuo Sun; Xin Cheng; Pengyu Han; Yinge Zhang; Dianxing Sun
Journal:  Virol J       Date:  2020-07-01       Impact factor: 4.099

4.  Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza.

Authors:  Yingying Zhao; Min Lu; Lok Ting Lau; Jie Lu; Zifen Gao; Jinhua Liu; Albert Cheung Hoi Yu; Qi Cao; Juxiang Ye; Michael A McNutt; Jiang Gu
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.